Positive results from early trial of drug that could protect brain cells
Date
A year after Duodopa was funded by NHS England we reflect on the importance of campaigning for people affected by Parkinson's and how you can get involved.
7 of the world’s largest pharmaceutical companies have signed up to a ground-breaking new initiative to improve clinical trials for Parkinson's.
Researchers at the University of Bristol have discovered that a common dementia drug, rivastigmine, could reduce falls in people with Parkinson's.
Our Media team has been awarded a special runners-up prize in the PR team of the year category at the Charity Times Awards for their work on highlighting Parkinson's Awareness Week 2012.